Campbell & CO Investment Adviser LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$533,317
-63.3%
6,264
-64.3%
0.10%
-64.9%
Q1 2023$1,453,918
+28.8%
17,570
+22.5%
0.27%
+0.4%
Q4 2022$1,128,392
+432.3%
14,347
+341.9%
0.27%
+373.7%
Q2 2022$212,000
-23.2%
3,247
+35.1%
0.06%
-32.9%
Q4 2019$276,000
-18.1%
2,403
-9.9%
0.08%
-33.1%
Q3 2019$337,0002,6680.13%
Other shareholders
HAEMONETICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders